TechnoDerma Medicines
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A dermatology-focused biotech developing novel biologic drugs for inflammatory skin diseases.
Dermatology
Technology Platform
A biologic drug discovery platform targeting novel immunology pathways involved in chronic inflammatory skin diseases.
Opportunities
Can address remaining unmet needs in dermatology, such as for patients non-responsive to current biologics.
Risk Factors
Clinical failure risk is high, and commercial traction is difficult against entrenched, highly effective competitors.
Competitive Landscape
Must compete against well-established, blockbuster biologic drugs from global pharma giants in the dermatology space.